Delivery Order SPE2DB20D2014-SPE2DB24FB28J
Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $2.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $15,883.20 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has been awarded numerous pharmaceutical and medical supply contracts by DLA to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,792.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This award is under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to deliver...
- This is a $35,815.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a medical product, with a completion date of June 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $31,766.40 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will deliver the pharmaceutical items to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $1,323.60 and a period of performance through March 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML vaccines. The contract has a ceiling value of $4,885.04 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a firm fixed price, with a potential value of $22,283.33, and a completion date of March 4, 2024. There is no set-aside designation for this award, which is a delivery order under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $3,394.70 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $7,942.04 to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,647.20 firm fixed-price contract is for the provision of VAXNEUVANCE 0.5 ML syringes, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB28JDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB20D2014|SPE2DB24FB28J) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This $2,840.23 award has an ultimate completion date of March 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025 to deliver a wide range of pharmaceutical products and medical supplies to military treatment programs and facilities. The IDC was awarded solely to AmerisourceBergen Drug Corp with no set-aside designation. This current award is issued under that larger IDC contract vehicle.
Generated 6/7/24, 11:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 3/8/24 |